- Home
- WNC vs ABUS Comparison
WNC vs ABUS Comparison
Compare WNC & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNC
- ABUS
- Stock Information
- Founded
- WNC 1985
- ABUS N/A
- Country
- WNC United States
- ABUS United States
- Employees
- WNC N/A
- ABUS N/A
- Industry
- WNC Construction/Ag Equipment/Trucks
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- WNC Industrials
- ABUS Health Care
- Exchange
- WNC Nasdaq
- ABUS Nasdaq
- Market Cap
- WNC 713.8M
- ABUS 629.1M
- IPO Year
- WNC 1991
- ABUS N/A
- Fundamental
- Price
- WNC $15.79
- ABUS $3.21
- Analyst Decision
- WNC Hold
- ABUS Strong Buy
- Analyst Count
- WNC 1
- ABUS 4
- Target Price
- WNC $18.00
- ABUS $5.50
- AVG Volume (30 Days)
- WNC 772.9K
- ABUS 876.5K
- Earning Date
- WNC 01-29-2025
- ABUS 02-27-2025
- Dividend Yield
- WNC 2.51%
- ABUS N/A
- EPS Growth
- WNC N/A
- ABUS N/A
- EPS
- WNC N/A
- ABUS N/A
- Revenue
- WNC $2,126,025,999.00
- ABUS $6,742,000.00
- Revenue This Year
- WNC N/A
- ABUS N/A
- Revenue Next Year
- WNC N/A
- ABUS N/A
- P/E Ratio
- WNC N/A
- ABUS N/A
- Revenue Growth
- WNC N/A
- ABUS N/A
- 52 Week Low
- WNC $15.35
- ABUS $2.27
- 52 Week High
- WNC $30.07
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- WNC 32.68
- ABUS 43.07
- Support Level
- WNC $15.35
- ABUS $3.16
- Resistance Level
- WNC $17.16
- ABUS $3.38
- Average True Range (ATR)
- WNC 0.65
- ABUS 0.14
- MACD
- WNC -0.05
- ABUS 0.00
- Stochastic Oscillator
- WNC 20.00
- ABUS 19.51
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.